Aandeel SKVI SKINVISIBLE, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Skinvisible, Inc.

Aandelen

SKVI

US8307032032

Beurs gesloten - OTC Markets
Andere beurzen
 21:58:14 10-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,101 USD +62,64% Intraday-grafiek van Skinvisible, Inc. 0,00% +20,53%
16/04 Skinvisible, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
2023 Skinvisible, Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Skinvisible Announces Significant Progress in Licensee's Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Skinvisible, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Skinvisible, Inc. Auditor Raises 'Going Concern' Doubt
SKINVISIBLE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
SKINVISIBLE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Skinvisible, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
SKINVISIBLE : Management's Discussion and Analysis of Financial Condition and Results of Operations Forward-Looking Statements (form 10-Q)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers SKVI
  4. Nieuws Skinvisible, Inc.
  5. Andere talen